|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics. 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Van Cutsem E, Nordlinger B, Adam R, Köhne
CH, Pozzo C, Poston G, Ychou M and Rougier P; European Colorectal
Metastases Treatment Group, : Towards a pan-European consensus on
the treatment of patients with colorectal liver metastases. Eur J
Cancer. 42:2212–2221. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Davies RJ, Miller R and Coleman N:
Colorectal cancer screening: Prospects for molecular stool
analysis. Nat Rev Cancer. 5:199–209. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schee K, Boye K, Abrahamsen TW, Fodstad Ø
and Flatmark K: Clinical relevance of microRNA miR-21, miR-31,
miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer. BMC
Cancer. 12:5052012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang R, Ma J, Wu Q, Xia J, Miele L, Sarkar
FH and Wang Z: Functional role of miR-34 family in human cancer.
Curr Drug Targets. 14:1185–1191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Agostini M and Knight RA: miR-34: From
bench to bedside. Oncotarget. 5:872–881. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wiggins JF, Ruffino L, Kelnar K, Omotola
M, Patrawala L, Brown D and Bader AG: Development of a lung cancer
therapeutic based on the tumor suppressor microRNA-34. Cancer Res.
70:5923–5930. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Di Martino MT, Leone E, Amodio N, Foresta
U, Lionetti M, Pitari MR, Cantafio ME, Gullà A, Conforti F, Morelli
E, et al: Synthetic miR-34a mimics as a novel therapeutic agent for
multiple myeloma: In vitro and in vivo evidence. Clin Cancer Res.
18:6260–6270. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Welch C, Chen Y and Stallings RL:
MicroRNA-34a functions as a potential tumor suppressor by inducing
apoptosis in neuroblastoma cells. Oncogene. 26:5017–5022. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cole KA, Attiyeh EF, Mosse YP, Laquaglia
MJ, Diskin SJ, Brodeur GM and Maris JM: A functional screen
identifies miR-34a as a candidate neuroblastoma tumor suppressor
gene. Mol Cancer Res. 6:735–742. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Y, Guessous F, Zhang Y, Dipierro C,
Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen
TD, et al: MicroRNA-34a inhibits glioblastoma growth by targeting
multiple oncogenes. Cancer Res. 69:7569–7576. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li WB, Ma MW, Dong LJ, Wang F, Chen LX and
Li XR: MicroRNA-34a targets notch1 and inhibits cell proliferation
in glioblastoma multiforme. Cancer Biol Ther. 12:477–483. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pang RT, Leung CO, Ye TM, Liu W, Chiu PC,
Lam KK, Lee KF and Yeung WS: MicroRNA-34a suppresses invasion
through downregulation of Notch1 and Jagged1 in cervical carcinoma
and choriocarcinoma cells. Carcinogenesis. 31:1037–1044. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang S, Li Y, Gao J, Zhang T, Li S, Luo A,
Chen H, Ding F, Wang X and Liu Z: MicroRNA-34 suppresses breast
cancer invasion and metastasis by directly targeting Fra-1.
Oncogene. 32:4294–4303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tazawa H, Tsuchiya N, Izumiya M and
Nakagama H: Tumor-suppressive miR-34a induces senescence-like
growth arrest through modulation of the E2F pathway in human colon
cancer cells. Proc Natl Acad Sci USA. 104:pp. 15472–15477. 2007;
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lefort K, Brooks Y, Ostano P, Cario-André
M, Calpini V, Guinea-Viniegra J, Albinger-Hegyi A, Hoetzenecker W,
Kolfschoten I, Wagner EF, et al: A miR-34a-SIRT6 axis in the
squamous cell differentiation network. EMBO J. 32:2248–2263. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rokavec M, Öner MG, Li H, Jackstadt R,
Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, et
al: IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated
colorectal cancer invasion and metastasis. J Clin Invest.
124:1853–1867. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hahn S, Jackstadt R, Siemens H, Hünten S
and Hermeking H: SNAIL and miR-34a feed-forward regulation of
ZNF281/ZBP99 promotes epithelial-mesenchymal transition. EMBO J.
32:3079–3095. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nalls D, Tang SN, Rodova M, Srivastava RK
and Shankar S: Targeting epigenetic regulation of miR-34a for
treatment of pancreatic cancer by inhibition of pancreatic cancer
stem cells. PLoS One. 6:e240992011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bu P, Chen KY, Chen JH, Wang L, Walters J,
Shin YJ, Goerger JP, Sun J, Witherspoon M, Rakhilin N, et al: A
microRNA miR-34a-regulated bimodal switch targets Notch in colon
cancer stem cells. Cell Stem Cell. 12:602–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng CY, Hwang CI, Corney DC,
Flesken-Nikitin A, Jiang L, Oner GM, Munroe RJ, Schimenti JC,
Hermeking H and Nikitin AY: miR-34 cooperates with p53 in
suppression of prostate cancer by joint regulation of stem cell
compartment. Cell Rep. 6:1000–1007. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu C and Tang DG: MicroRNA regulation of
cancer stem cells. Cancer Res. 71:5950–5954. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wittekind C: 2010 TNM system: On the 7th
edition of TNM classification of malignant tumors. Pathologe.
31:331–332. 2010.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leong KG and Karsan A: Recent insights
into the role of Notch signaling in tumorigenesis. Blood.
107:2223–2233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zagouras P, Stifani S, Blaumueller CM,
Carcangiu ML and Artavanis-Tsakonas S: Alterations in Notch
signaling in neoplastic lesions of the human cervix. Proc Natl Acad
Sci USA. 92:pp. 6414–6418. 1995; View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Du R, Sun W, Xia L, Zhao A, Yu Y, Zhao L,
Wang H, Huang C and Sun S: Hypoxia-induced down-regulation of
microRNA-34a promotes EMT by targeting the Notch signaling pathway
in tubular epithelial cells. PLoS One. 7:e307712012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Y, Wu B, Chamberlain AA, Lui W,
Koirala P, Susztak K, Klein D, Taylor V and Zhou B: Endocardial to
myocardial notch-wnt-bmp axis regulates early heart valve
development. PLoS One. 8:e602442013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zavadil J, Cermak L, Soto-Nieves N and
Böttinger EP: Integration of TGF-beta/Smad and Jagged1/Notch
signalling in epithelial-to-mesenchymal transition. EMBO J.
23:1155–1165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Valastyan S, Reinhardt F, Benaich N,
Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL and
Weinberg RA: A pleiotropically acting microRNA, miR-31, inhibits
breast cancer metastasis. Cell. 137:1032–1046. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hermeking H: The miR-34 family in cancer
and apoptosis. Cell Death Differ. 17:193–199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hermeking H: p53 enters the microRNA
world. Cancer Cell. 12:414–418. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chang TC, Wentzel EA, Kent OA,
Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M,
Ferlito M, Lowenstein CJ, et al: Transactivation of miR-34a by p53
broadly influences gene expression and promotes apoptosis. Mol
Cell. 26:745–752. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu C, Kelnar K, Liu B, Chen X,
Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, et
al: The microRNA miR-34a inhibits prostate cancer stem cells and
metastasis by directly repressing CD44. Nat Med. 2:211–215. 2011.
View Article : Google Scholar
|
|
41
|
Wu J, Wu G, Lv L, Ren YF, Zhang XJ, Xue
YF, Li G, Lu X, Sun Z and Tang KF: MicroRNA-34a inhibits migration
and invasion of colon cancer cells via targeting to Fra-1.
Carcinogenesis. 33:519–528. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li XJ, Ren ZJ and Tang JH: MicroRNA-34a: A
potential therapeutic target in human cancer. Cell Death Dis.
5:e13272014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ntziachristos P, Lim JS, Sage J and
Aifantis I: From fly wings to targeted cancer therapies: A
centennial for notch signaling. Cancer Cell. 25:318–334. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: Cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kopan R and Ilagan MX: The canonical Notch
signaling pathway: Unfolding the activation mechanism. Cell.
137:216–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dotto GP: Notch tumor suppressor function.
Oncogene. 27:5115–5123. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Su BH, Qu J, Song M, Huang XY, Hu XM, Xie
J, Zhao Y, Ding LC, She L, Chen J, et al: NOTCH1 signaling
contributes to cell growth, anti-apoptosis and metastasis in
salivary adenoid cystic carcinoma. Oncotarget. 5:6885–6895. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang L, Dong Y, Zhu N, Tsoi H, Zhao Z, Wu
CW, Wang K, Zheng S, Ng SS, Chan FK, et al: microRNA-139-5p exerts
tumor suppressor function by targeting NOTCH1 in colorectal cancer.
Mol Cancer. 13:1242014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang H, Wang X, Xu J and Sun Y: Notch1
activation is a poor prognostic factor in patients with gastric
cancer. Br J Cancer. 110:2283–2290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang J, Francois R, Iyer R, Seshadri M,
Zajac-Kaye M and Hochwald SN: Current understanding of the
molecular biology of pancreatic neuroendocrine tumors. J Natl
Cancer Inst. 105:1005–1017. 2013. View Article : Google Scholar : PubMed/NCBI
|
